Eurobio Scientific
Company Profile
Business description
Eurobio Scientific operates in the fields of in vitro diagnostics and life sciences. In the Diagnostics sector, it supplies hospital and private diagnostic laboratories with instruments and reagents for medical analyses prescribed by physicians. In the Life Sciences sector, it supplies research laboratories of pharmaceutical groups, biotechnology companies, and public institutions with products required for their R&D programmes, including antibodies that it develops and manufactures. Its products and activities include Transplantation, Oncology, Infectious Diseases, and Life Sciences. The Group generates maximum revenue from France.
Contact
7 Avenue De Scandinavie
ZA De Courtaboeuf
Les Ulis91940
FRAT: +33 169796480
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
290
Stocks News & Analysis
stocks
ASX top pick remains cheap despite weaker consumer confidence
stocks
Chart of the Week: Aussie dividend yields below 10-year average
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,144.70 | 60.50 | -0.66% |
| CAC 40 | 8,139.00 | 66.37 | -0.81% |
| DAX 40 | 25,820.36 | 504.65 | -1.92% |
| Dow JONES (US) | 51,285.73 | 237.33 | -0.46% |
| FTSE 100 | 10,673.94 | 108.72 | -1.01% |
| HKSE | 24,481.86 | 315.12 | -1.27% |
| NASDAQ | 24,579.43 | 264.43 | 1.09% |
| Nikkei 225 | 57,434.77 | 3,643.13 | -5.96% |
| NZX 50 Index | 13,998.50 | 92.47 | -0.66% |
| S&P 500 | 7,376.86 | 23.13 | 0.31% |
| S&P/ASX 200 | 9,020.80 | 44.30 | -0.49% |
| SSE Composite Index | 3,649.18 | 40.73 | -1.10% |